These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8740643)

  • 21. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
    Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
    J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding.
    Pasic R; Djulbegovic B; Wittliff JL
    J Clin Lab Anal; 1990; 4(6):430-6. PubMed ID: 2283562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers.
    Smyth CM; Benn DE; Reeve TS
    Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraffin section immunocytochemistry and cytosol-based ligand-binding assays for ER and PR detection in breast cancer: the time has come for more objectivity.
    Goussard J
    Cancer Lett; 1998 Oct; 132(1-2):61-6. PubMed ID: 10397454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen and progesterone receptor assays, by the EIA method (Abbott), of low-speed supernates of breast-cancer homogenates.
    Hähnel R; Avenell MH; Hähnel E
    Clin Chem; 1989 Nov; 35(11):2226-7. PubMed ID: 2684449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay.
    Krambovitis E; Hatzidakis G; Hatzoglou A; Romain S; Durand A; Stefanakis A; Castanas E
    Clin Chem; 1995 Jan; 41(1):48-53. PubMed ID: 7813080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen and progesterone measurement and its quality control in breast cancer: a reappraisal.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M
    Int J Biol Markers; 1986; 1(1):15-28. PubMed ID: 3320222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
    Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
    J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
    Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
    Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of an immunoenzymatic assay for determining estrogen and progesterone receptors in breast tumors].
    Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S; Faryńska E
    Ginekol Pol; 1992; 63(10):528-33. PubMed ID: 1305562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic and clinical relevance of hormonal influence in breast cancer.
    Pollow K; Grill HJ; Kreienberg R; Hoffmann G; Beck T; Schmidt-Gollwitzer K; Manz B
    Recent Results Cancer Res; 1990; 118():196-224. PubMed ID: 2236839
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytologic diagnosis of estrogen and progesterone receptors in breast imprints.
    Sasaki M; Morimoto K; Koh M; Wakasa K; Haba T; Kinoshita H
    Acta Cytol; 2002; 46(6):1056-60. PubMed ID: 12462082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
    Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
    Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone receptor determination in human breast tumors by immunocytochemical and biochemical techniques.
    Cappelletti V; Patriarca C; Granata G; Cattoretti G; Coradini D; Di Fronzo G; Horwitz K
    Breast Cancer Res Treat; 1989 Nov; 14(2):217-25. PubMed ID: 2690973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods.
    Blankenstein MA; van der Meulen-Dijk C; Thijssen JH
    Clin Chim Acta; 1987 Jun; 165(2-3):189-95. PubMed ID: 3308181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay.
    Bilous AM; Tyler JP; Toppila M; Milliken J
    Pathology; 1987 Jul; 19(3):223-8. PubMed ID: 3324022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.
    Goussard J; Magdelenat H; Martin PM; Lechevrel C; Roussel G
    Bull Cancer; 1988; 75(8):771-82. PubMed ID: 3052654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.